Novavax Inc. (NVAX) Stock’s Detailed Analysis

Novavax Inc. (NASDAQ:NVAX) has a beta value of 1.60 and has seen 7.12 million shares traded in the last trading session. The company, currently valued at $3.85B, closed the last trade at $51.97 per share which meant it lost -$2.46 on the day or -4.52% during that session. The NVAX stock price is -434.54% off its 52-week high price of $277.80 and 32.88% above the 52-week low of $34.88. If we look at the company’s 10-day average daily trading volume, we find that it stood at 10.74 million shares traded. The 3-month trading volume is 7.25 million shares.

Sporting -4.52% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on Monday, 07/18/22 when the NVAX stock price touched $51.97 or saw a rise of 29.43%. Year-to-date, Novavax Inc. shares have moved -63.68%, while the 5-day performance has seen it change -22.61%. Over the past 30 days, the shares of Novavax Inc. (NASDAQ:NVAX) have changed 26.05%. Short interest in the company has seen 12.17 million shares shorted with days to cover at 2.84.

3 Tiny Stocks Primed to Explode The world’s greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We’ve set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored

Wall Street analysts have a consensus price target for the stock at $149.17, which means that the shares’ value could jump 65.16% from current levels. The projected low price target is $35.00 while the price target rests at a high of $207.00. In that case, then, we find that the current price level is -298.31% off the targeted high while a plunge would see the stock lose 32.65% from current levels.

Novavax Inc. (NVAX) estimates and forecasts

Figures show that Novavax Inc. shares have outperformed across the wider relevant industry. The company’s shares have lost -60.08% over the past 6 months, with this year growth rate of 216.17%, compared to 1.10% for the industry. Other than that, the company has, however, increased its growth outlook for the 2022 fiscal year revenue. Growth estimates for the current quarter are 210.70% and 254.10% for the next quarter. Revenue growth from the last financial year stood is estimated to be 273.80%.

6 analysts offering their estimates for the company have set an average revenue estimate of $998.78 million for the current quarter. 6 have an estimated revenue figure of $1.15 billion for the next quarter concluding in Sep 2022.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -2.50% over the past 5 years. Earnings growth for 2022 is a modest -222.50% while over the next 5 years, the company’s earnings are expected to decrease by 0.00%.

NVAX Dividends

Novavax Inc. is expected to release its next earnings report between February 28 and March 04 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Novavax Inc. (NASDAQ:NVAX)’s Major holders

Insiders own 0.29% of the company shares, while shares held by institutions stand at 43.96% with a share float percentage of 44.08%. Investors are also buoyed by the number of investors in a company, with Novavax Inc. having a total of 587 institutions that hold shares in the company. The top two institutional holders are Vanguard Group, Inc. (The) with over 6.9 million shares worth more than $986.75 million. As of Dec 30, 2021, Vanguard Group, Inc. (The) held 8.83% of shares outstanding.

The other major institutional holder is Blackrock Inc., with the holding of over 4.52 million shares as of Mar 30, 2022. The firm’s total holdings are worth over $332.59 million and represent 5.78% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Small-Cap Index Fund. As of Dec 30, 2021, the former fund manager holds about 2.75% shares in the company for having 2.15 million shares of worth $307.43 million while later fund manager owns 1.9 million shares of worth $272.49 million as of Dec 30, 2021, which makes it owner of about 2.44% of company’s outstanding stock.